Clinical Trial Update: A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the safety and efficacy of mRNA-1403 in adults to prevent acute gastroenteritis, including norovirus-associated cases; the trial is a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteritis
• Norovirus Gastroenteritis

Drugs mentioned

• mRNA-1403

Snippet

Sponsor: ModernaTX, Inc. | Conditions: Acute Gastroenteritis, Norovirus Acute Gastroenteritis | Phase 3 | Status: ACTIVE_NOT_RECRUITING